Health TrialsbyHealthPanel

Platinum-sensitive Recurrent Ovarian Cancer

1

Review clinical trials related to Platinum-sensitive Recurrent Ovarian Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase III Study of HS-20089 With Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer

This is a Phase III study evaluating the efficacy of HS-20089 in combination with bevacizumab versus investigator's choice of platinum-based chemotherapy in combination with bevacizumab in participants with platinum-sensitive recurrent ovarian cancer (PSOC).

Participants needed: 460
Trial details
Phase: Phase 3Age: 18+Biological sex: FemaleType: InterventionalSponsor: Hansoh BioMedical R&D CompanyUpdated: Sep 16, 2026Locations: 39
Eligibility criteria

Female, aged 18 years or older (≥18 years) [+6]

1. Prior treatment with topoisomerase I inhibitors; cytotoxic chemotherapy agent...

Read more